Cargando…

Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials

The specificity of acupoint indication (i.e., reverse inference—diseases for which an acupoint could be used) might differ from the specificity of acupoint selection (i.e., forward inference—acupoints used for a disease). In this study, we explore acupoint specificity through reverse inferences from...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ye-Chae, Lee, In-Seon, Ryu, Yeonhee, Lee, Ye-Seul, Chae, Younbyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564320/
https://www.ncbi.nlm.nih.gov/pubmed/32962229
http://dx.doi.org/10.3390/jcm9093027
_version_ 1783595687482490880
author Hwang, Ye-Chae
Lee, In-Seon
Ryu, Yeonhee
Lee, Ye-Seul
Chae, Younbyoung
author_facet Hwang, Ye-Chae
Lee, In-Seon
Ryu, Yeonhee
Lee, Ye-Seul
Chae, Younbyoung
author_sort Hwang, Ye-Chae
collection PubMed
description The specificity of acupoint indication (i.e., reverse inference—diseases for which an acupoint could be used) might differ from the specificity of acupoint selection (i.e., forward inference—acupoints used for a disease). In this study, we explore acupoint specificity through reverse inferences from the dataset of prescribed acupoints for a certain disease in clinical trials. We searched acupuncture treatment regimens in randomized controlled trials included in the Cochrane Database of Systematic Reviews. For forward inference, the acupoints prescribed for each disease were quantified. For reverse inference, diseases for each acupoint were quantified. Data were normalized using Z-scores. Bayes factor correction was performed to adjust for the prior probability of diseases. The specificities of acupoint selections in 30 diseases were determined using forward inference. The specificities of acupoint indications regarding 49 acupoints were identified using reverse inference and then subjected to Bayes factor correction. Two types of acupoint indications were identified for 24 acupoints: regional and distal. Our approach suggests that the specificity of acupoint indication can be inferred from clinical data using reverse inference. Acupoint indication will improve our understanding of acupoint specificity and will lead to the establishment of a new model of analysis and educational resources for acupoint characteristics.
format Online
Article
Text
id pubmed-7564320
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75643202020-10-26 Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials Hwang, Ye-Chae Lee, In-Seon Ryu, Yeonhee Lee, Ye-Seul Chae, Younbyoung J Clin Med Article The specificity of acupoint indication (i.e., reverse inference—diseases for which an acupoint could be used) might differ from the specificity of acupoint selection (i.e., forward inference—acupoints used for a disease). In this study, we explore acupoint specificity through reverse inferences from the dataset of prescribed acupoints for a certain disease in clinical trials. We searched acupuncture treatment regimens in randomized controlled trials included in the Cochrane Database of Systematic Reviews. For forward inference, the acupoints prescribed for each disease were quantified. For reverse inference, diseases for each acupoint were quantified. Data were normalized using Z-scores. Bayes factor correction was performed to adjust for the prior probability of diseases. The specificities of acupoint selections in 30 diseases were determined using forward inference. The specificities of acupoint indications regarding 49 acupoints were identified using reverse inference and then subjected to Bayes factor correction. Two types of acupoint indications were identified for 24 acupoints: regional and distal. Our approach suggests that the specificity of acupoint indication can be inferred from clinical data using reverse inference. Acupoint indication will improve our understanding of acupoint specificity and will lead to the establishment of a new model of analysis and educational resources for acupoint characteristics. MDPI 2020-09-20 /pmc/articles/PMC7564320/ /pubmed/32962229 http://dx.doi.org/10.3390/jcm9093027 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hwang, Ye-Chae
Lee, In-Seon
Ryu, Yeonhee
Lee, Ye-Seul
Chae, Younbyoung
Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials
title Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials
title_full Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials
title_fullStr Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials
title_full_unstemmed Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials
title_short Identification of Acupoint Indication from Reverse Inference: Data Mining of Randomized Controlled Clinical Trials
title_sort identification of acupoint indication from reverse inference: data mining of randomized controlled clinical trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564320/
https://www.ncbi.nlm.nih.gov/pubmed/32962229
http://dx.doi.org/10.3390/jcm9093027
work_keys_str_mv AT hwangyechae identificationofacupointindicationfromreverseinferencedataminingofrandomizedcontrolledclinicaltrials
AT leeinseon identificationofacupointindicationfromreverseinferencedataminingofrandomizedcontrolledclinicaltrials
AT ryuyeonhee identificationofacupointindicationfromreverseinferencedataminingofrandomizedcontrolledclinicaltrials
AT leeyeseul identificationofacupointindicationfromreverseinferencedataminingofrandomizedcontrolledclinicaltrials
AT chaeyounbyoung identificationofacupointindicationfromreverseinferencedataminingofrandomizedcontrolledclinicaltrials